Global Market for Exosome Diagnostics, Therapeutics, and Research Tools (2021-2028) Featuring Bio-Techne, Exosomics, and System Biosciences - An Evaluation of New Commercial Opportunities ...
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028. The report includes: 14 data tables and 77 additional tables Analysis of the global markets and global trends for exosome diagnostics and therapeutics, with revenue data for 2021-2022, estimates for 2023, forecasts for 2024, and projected CAGRs through 2028 Estimate of the current market size and revenue growth prospects, along with a market share analysis based on product, application, end user and region Facts and figures pertaining to the market drivers, opportunities and restraints, and the impacts of macroeconomic variables Discussion of emerging technologies, regulations and R&D efforts Evaluation of new commercial opportunities in the diagnostics, therapeutics and research tools markets, and an assessment of trends, products and assay
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Bio-Techne Co. (NASDAQ: TECH) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $95.00 price target on the stock.MarketBeat
- Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Bio-Techne Co. (NASDAQ: TECH) had its price target raised by analysts at Robert W. Baird from $73.00 to $81.00. They now have an "outperform" rating on the stock.MarketBeat
- Bio-Techne Corporation (NASDAQ:TECH) Shares Could Be 25% Above Their Intrinsic Value Estimate [Yahoo! Finance]Yahoo! Finance
- Bio-Techne beats third-quarter estimates on improving demand for biotech products [Reuters]Reuters
TECH
Earnings
- 5/1/24 - Beat
TECH
Sec Filings
- 5/3/24 - Form 4
- 5/3/24 - Form 3
- 5/1/24 - Form 8-K
- TECH's page on the SEC website